The Global Heart-lung Machine Market was valued at USD 385.3 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 606.7 million by 2035.
The market expansion is driven primarily by the rising prevalence of cardiovascular diseases and the increasing number of organ transplants and open-heart surgeries worldwide. Heart-lung machines, also referred to as cardiopulmonary bypass (CPB) devices, temporarily assume the functions of the heart and lungs during surgery by oxygenating blood, removing carbon dioxide, and maintaining circulation. Technological innovations, including improved oxygenator systems and advanced blood pump designs, have enhanced efficiency, safety, and usability. Compact and high-performance devices are now enabling more precise circulation control, reduced surgical complications, and broader adoption in diverse healthcare settings. The growing demand for minimally invasive procedures, coupled with improved perioperative outcomes, continues to propel the use of heart-lung machines globally. Additionally, better reimbursement frameworks, expanding outpatient surgical facilities, and strategic investments by key players are supporting steady market growth.
The single roller pump segment is expected to grow at a CAGR of 4.4% to reach USD 354 million by 2035. Its popularity stems from reliable, controlled blood flow, cost-effectiveness, and widespread use in cardiac surgeries. These pumps offer stable extracorporeal membrane oxygenation, which is crucial for procedures requiring prolonged circulation, making them a preferred choice across hospitals and emerging healthcare facilities.
The ambulatory surgical centers segment accounted for USD 145.6 million in 2025 and is projected to reach USD 243 million by 2035, growing at a CAGR of 5.3%. Growth in this segment is fueled by the increasing adoption of minimally invasive cardiac procedures in outpatient settings, alongside compact, cost-efficient heart-lung machine solutions that support efficient perioperative care.
U.S. Heart-lung Machine Market reached USD 144.6 million in 2025 and is expected to grow at a CAGR of 4.1% from 2026 to 2035. High annual cardiac surgery volumes, favorable reimbursement policies, substantial R&D investment, and the presence of major manufacturers strengthen the U.S. position as a leading market for heart-lung machines.
Prominent players operating in the Global Heart-lung Machine Market include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, Hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, Raumedic, and TERUMO. Key strategies adopted by companies in the Global Heart-lung Machine Market include continuous R&D for advanced oxygenation and pump technologies, development of compact and portable devices for outpatient facilities, strategic partnerships with hospitals and surgical centers, expansion of global distribution networks, and ensuring regulatory compliance across multiple regions. Firms also focus on offering training programs, technical support, and after-sales services to improve adoption and customer loyalty, while optimizing production efficiency and supply chains to enhance competitiveness and market penetration.
This product will be delivered within 2-4 business days.
The market expansion is driven primarily by the rising prevalence of cardiovascular diseases and the increasing number of organ transplants and open-heart surgeries worldwide. Heart-lung machines, also referred to as cardiopulmonary bypass (CPB) devices, temporarily assume the functions of the heart and lungs during surgery by oxygenating blood, removing carbon dioxide, and maintaining circulation. Technological innovations, including improved oxygenator systems and advanced blood pump designs, have enhanced efficiency, safety, and usability. Compact and high-performance devices are now enabling more precise circulation control, reduced surgical complications, and broader adoption in diverse healthcare settings. The growing demand for minimally invasive procedures, coupled with improved perioperative outcomes, continues to propel the use of heart-lung machines globally. Additionally, better reimbursement frameworks, expanding outpatient surgical facilities, and strategic investments by key players are supporting steady market growth.
The single roller pump segment is expected to grow at a CAGR of 4.4% to reach USD 354 million by 2035. Its popularity stems from reliable, controlled blood flow, cost-effectiveness, and widespread use in cardiac surgeries. These pumps offer stable extracorporeal membrane oxygenation, which is crucial for procedures requiring prolonged circulation, making them a preferred choice across hospitals and emerging healthcare facilities.
The ambulatory surgical centers segment accounted for USD 145.6 million in 2025 and is projected to reach USD 243 million by 2035, growing at a CAGR of 5.3%. Growth in this segment is fueled by the increasing adoption of minimally invasive cardiac procedures in outpatient settings, alongside compact, cost-efficient heart-lung machine solutions that support efficient perioperative care.
U.S. Heart-lung Machine Market reached USD 144.6 million in 2025 and is expected to grow at a CAGR of 4.1% from 2026 to 2035. High annual cardiac surgery volumes, favorable reimbursement policies, substantial R&D investment, and the presence of major manufacturers strengthen the U.S. position as a leading market for heart-lung machines.
Prominent players operating in the Global Heart-lung Machine Market include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, Hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, Raumedic, and TERUMO. Key strategies adopted by companies in the Global Heart-lung Machine Market include continuous R&D for advanced oxygenation and pump technologies, development of compact and portable devices for outpatient facilities, strategic partnerships with hospitals and surgical centers, expansion of global distribution networks, and ensuring regulatory compliance across multiple regions. Firms also focus on offering training programs, technical support, and after-sales services to improve adoption and customer loyalty, while optimizing production efficiency and supply chains to enhance competitiveness and market penetration.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Type, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Heart-lung Machine market report include:- BRAILE
- Edwards
- ELITE LIFE CARE
- EUROSETS
- FRESENIUS MEDICAL CARE
- GETINGE
- HEART CARE INDIA CO
- hemovent
- Jarvik HEART
- LivaNova
- Medtronic
- NIPRO
- Palex
- Philips
- raumedic
- TERUMO
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 385.3 Million |
| Forecasted Market Value ( USD | $ 606.7 Million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
